Cardene Representative 40mg Container Label 1 Of 2.jpg (Image 02)
Cardene Representative 40mg Container Label 2 Of 2.jpg (Image 03)
Container Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
For Intravenous Infusion Only.
40 mg in 200 mL
(0.2 mg/mL)
GALAXY
Single-Dose Container
Discard unused portion
200 mL
Iso-osmotic
NDC 43066-016-10
Rx only
Sterile, Nonpyrogenic
Each mL contains 0.2 mg NICARDIPINE HYDROCHLORIDE in 8.3 mg SODIUM
CHLORIDE, USP with 0.0384 mg CITRIC ACID ANHYDROUS, USP and 3.84
mg SORBITOL, NF. HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may
have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are
found, discard bag as sterility may be impaired. Do not use unless solution
is clear. Do not add supplemental medication. Must not be used in series
connections.
STORAGE: Store at controlled room temperature 20° to 25° C (68° to 77° F);
refer to USP Controlled Room Temperature. Protect from freezing. Avoid
excessive heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY
TO USE.
U.S. Patent Numbers 7612102 and 7659291
Baxter and Galaxy are registered trademarks of Baxter International Inc.
Cardene is a registered trademark of Chiesi USA, Inc. and is used under license.
Code 2G3444
Baxter Logo
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-34-00-2344
*BAR CODE
POSITION ONLY
343066016104
Cardene Representative 40mg Carton Label 1 Of 2.jpg (Image 04)
Cardene Representative 40mg Carton Label 2 Of 2.jpg (Image 05)
Carton Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
NDC 43066-016-10 Rx only
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
For Intravenous Infusion Only.
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
Code 2G3444
Baxter Logo
Baxter Healthcare Corporation Deerfield, IL 60015 USA
Made in the USA
40 mg in 200 mL
(0.2 mg/mL)
STORE IN CARTON
UNTIL READY TO USE
1 GALAXY Single Dose Container
Discard unused portion
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
(0.2 mg/mL)
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
(0.2 mg/mL)
UNVARNISHED AREA FOR
LOT AND EXP.
UCC/EAN 128 BAR CODE POSITION
1.75” W (excluding quiet zone)
0.5” H (excluding human readable)
(01) 00343066016104
Iso-osmotic Sterile, nonpyrogenic
Each mL contains 0.2 mg NICARDIPINE HYDROCHLORIDE in 8.3 mg SODIUM CHLORIDE,
USP with 0.0384 mg CITRIC ACID ANHYDROUS, USP and 3.84 mg SORBITOL, NF.
HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are found, discard
bag as sterility may be impaired. Do not use unless solution is clear. Do not
add supplemental medication. Must not be used in series connections.
STORAGE: Store at controlled room temperature 20° to 25° C (68° to 77° F); refer to
USP Controlled Room Temperature. Protect from freezing. Avoid excessive
heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
U.S. Patent Numbers 7612102 and 7659291
Baxter and Galaxy are registered trademarks of Baxter International Inc.
Cardene is a registered trademark of Chiesi USA, Inc. and is used under license.
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-01-00-1677
CARDENE® I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
CARDENE® I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
Cardene Representative 20mg Container Label 1 Of 2.jpg (Image 06)
Cardene Representative 20mg Container Label 2 Of 2.jpg (Image 07)
Container Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
For Intravenous Infusion Only.
20 mg in 200 mL
(0.1 mg/mL)
GALAXY
Single-Dose Container
Discard unused portion
200 mL
Iso-osmotic
NDC 43066-009-10
Rx only
Sterile, Nonpyrogenic
Each mL contains 0.1 mg NICARDIPINE HYDROCHLORIDE in 8.6 mg SODIUM
CHLORIDE, USP with 0.0192 mg CITRIC ACID ANHYDROUS, USP and 1.92
mg SORBITOL, NF. HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may
have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are
found, discard bag as sterility may be impaired. Do not use unless solution
is clear. Do not add supplemental medication. Must not be used in series
connections.
STORAGE: Store at controlled room temperature 20° to 25° C (68° to 77° F);
refer to USP Controlled Room Temperature. Protect from freezing. Avoid
excessive heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY
TO USE.
U.S. Patent Numbers 7612102 and 7659291
Baxter and Galaxy are registered trademarks of Baxter International Inc.
CARDENE is a registered trademark of Chiesi USA, Inc. and is used under license
Code 2G3443
Baxter Logo
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-34-00-2345
*BAR CODE
POSITION ONLY
343066009106
Cardene Representative 20mg Carton Label 1 Of 2.jpg (Image 08)
Cardene Representative 20mg Carton Label 2 Of 2.jpg (Image 09)
Carton Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
NDC 43066-009-10 Rx only
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
For Intravenous Infusion Only.
Baxter Logo
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
Made in the USA
Code 2G3443
20 mg in 200 mL
(0.1 mg/ml)
STORE IN CARTON
UNTIL READY TO USE
1 GALAXY Single Dose Container
Discard unused portion
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
(0.1 mg/mL)
UNVARNISHED AREA FOR
LOT AND EXP.
UCC/EAN 128 BAR CODE POSITION
1.75” W (excluding quiet zone)
0.5” H (excluding human readable)
(01) 00343066009106
Iso-osmotic Sterile, nonpyrogenic
Each mL contains 0.1 mg NICARDIPINE HYDROCHLORIDE in 8.6 mg SODIUM CHLORIDE,
USP with 0.0192 mg CITRIC ACID ANHYDROUS, USP and 1.92 mg SORBITOL, NF.
HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are found, discard
bag as sterility may be impaired. Do not use unless solution is clear. Do not
add supplemental medication. Must not be used in series connections.
STORAGE: Store at controlled room temperature 20° to 25° C (68° to 77° F); refer to
USP Controlled Room Temperature. Protect from freezing. Avoid excessive
heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
U.S. Patent Numbers 7612102 and 7659291
Baxter and Galaxy are registered trademarks of Baxter International Inc.
Cardene is a registered trademark of Chiesi USA, Inc. and is used under license.
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-01-00-1734
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL